Autoantibodies against p16 protein-derived peptides may be a potential biomarker for non-small cell lung cancer. | Tumour Biol;35(3): 2047-51, 2014 Mar. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Autoantibodies against p16 protein-derived peptides may be a potential biomarker for non-small cell lung cancer.

Zhang, Cong; Ye, Leiguang; Guan, Songlei; Jin, Shunzi; Wang, Weili; Sun, Shilong; Lee, Kuang-Hui; Wei, Jun; Liu, Baogang.

Tumour Biol ; 35(3): 2047-51, 2014 Mar.

Article in En | MEDLINE | ID: mdl-24122232

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Autoantibodies / Biomarkers, Tumor / Carcinoma, Non-Small-Cell Lung / Cyclin-Dependent Kinase Inhibitor p16 / Lung Neoplasms Type of study: Diagnostic_studies / Prognostic_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Tumour Biol Journal subject: NEOPLASIAS Year: 2014 Document type: Article Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Autoantibodies / Biomarkers, Tumor / Carcinoma, Non-Small-Cell Lung / Cyclin-Dependent Kinase Inhibitor p16 / Lung Neoplasms Type of study: Diagnostic_studies / Prognostic_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Tumour Biol Journal subject: NEOPLASIAS Year: 2014 Document type: Article Country of publication: